Status: open
Indivior (Suboxone price fixing)
Defendant: Indivior
The manufacturer of Suboxone, an opioid addiction treatment, will pay $30 million to settle a case alleging that the pharmaceutical company conspired with other companies to raise the price of Suboxone. If you indirectly purchased or paid for Suboxone and/or its generic equivalents between Dec. 22, 2011, and Aug. 21, 2023, in any state other than Indiana or Ohio, you may be eligible for payment.